Treatment of acute rejection

Renal Failure

Volumn 18, Issue 3, 1996, Pages 433-443

  Thiel, G ^a   Binet, I ^a   Bock, A ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; POLYCLONAL ANTIBODY; STEROID; TACROLIMUS;

ACUTE KIDNEY FAILURE; CONFERENCE PAPER; DRUG MEGADOSE; GRAFT REJECTION; HUMAN; IMMUNOADSORPTION; IMMUNOCOMPETENCE; INTRAVENOUS DRUG ADMINISTRATION; MEDICAL DECISION MAKING; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRESCRIPTION; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0029896718     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.3109/08860229609052814     Document Type: Conference Paper

References (27)

1. Alamartine E, Bellakoul R, Berthoux F: Randomized prospective study comparing OKT3 and antithymocyte globulins for treatment of first acute cellular rejection of kidney allografts. Transpl Proc 26:273-274, 1994.
2. Alarcon-Zurita A, Ladefoged J: Treatment of acute allograft rejection with high doses of corticosteroids. Kidney Int 9:351-354, 1976.
3. Amemiya H, Dohi K, Otsubo O, Endo T, Nagano S, Ishibashi M, Hirano T, Sato K, Kurita T, Fukao K: Markedly enhanced therapeutic effect of deoxyspergualine on acute rejection when combined with methylprednisolone in kidney recipients. Transplant Proc 23:1087-1089, 1991.
4. Bell PRF, Calman KC, Wood RFM, Briggs JD, Paton AM, MacPherson SG: Reversal of acute clinical and experimental organ rejection using large doses of intravenous methlyprednisolone therapy Lancet 1:876-880, 1971.
5. Blümke M, Kirste G, Wanner U, Wilms H: Single center randomized trial using ATG versus OKT3 in steroid resistant rejection crisis after kidney transplantation. Transplant Proc 21:1747, 1989.
6. Bock HA, Gallati H, Zürcher RM, Bachofen M, Mihatsch MJ, Landmann J, Thiel G: A randomized prospective trial of prophylactic immunosuppression with ATG-Fresenius versus OKT3 after renal transplantation. Transplantation 6:830-840, 1995.
7. Deeb GM, Bolling SF, Steimle CN, Dawe JE, McKay AL, Richardson AM: A randomized prospective comparison of MALG with OKT3 for rescue therapy of acute myocardial rejection. Transplantation 51:180-183, 1991.
8. European Mycophenolate Mofetil Cooperative Study group: Placebo controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. Lancet 345:1321-1325, 1995.
9. Feduska NJ, Turcotte JG, Gikas PW, Bacon GE, Penner JA: Reversal of renal allograft rejection with intravenous methylprednisolone pulse therapy. J Surg Res 12:208-215, 1972.
10. Feucht HE, Schneeberger H, Hillebrand G, Burkhardt K, Weiss M, Riethmüller G, Land W, Albert E: Capillary deposition of C4d complement fragment and early graft loss. Kidney Int 43:1333-1338, 1993.
11. Godfrey AM, Salaman JR: Radiotherapy in treatment of acute rejection of human renal allografts. Lancet 1:938-939, 1976.
12. Grandtnerová B, Javorský P, Kolácný J, Hovoricová B, Dedic P, Laca L: Treatment of acute humoral rejection with plasmapheresis. Transplant Proc 27:934-935, 1995.
13. Hesse UJ, Wienand P, Baldamus C, Arns W: Preliminary results of a prospective randomized trial of ALG vs OKT3 for steroid resistant rejection after renal transplantation in the early postoperative period. Transplant Proc 22:2273-2274, 1990.
14. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Randhawa P, Carrieri G, McGauley J, Demetris AJ, Tzakis A, Fung JJ, Simmons RL, Hakala TR, Starzl TE: FK506 "rescue" for resistant rejection of acute renal allografts under primary cyclosporine immunosuppression. Transplantation 57:860-865, 1994.
15. Lui SF, Sweny P, Scoble JE, Varghese Z, Moorhead JF, Fernando OH: Low dose versus high dose intravenous methylprednisolone therapy for acute renal allograft rejection in patients receiving cyclosporin therapy. Nephrol Dial Transplant 5:320, 1990.
16. Mastrangelo F, Pretagostini R, Berloco P, Poli L, Cinti P, Patruno P, Alfonso L, Pompei L, Carboni F, Rizzelli S, Alfani D, Cortesini R: Immunoadsorption with protein A in humoral acute rejection of kidney transplants: multicenter experience. Transplant Proc 27:892-895, 1995.
17. Mussche MM, Ringoir SM, Lameire NN. High intravenous doses of methylprednisolone for acute renal allograft rejection. Nephron 16:287-291, 1976.
18. Ortho Multicenter Transplant Study Group: A randomized trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants, N Engl J Med 313:337-342, 1985.
19. Park GD, Bartucci M, Smith MC: High-versus low-dose methylprednisolone for acute rejection episodes in renal transplantation. Nephron 36:80-83, 1984.
20. Parlevliet KJ, Schellekens PTA: Monoclonal antibodies in renal transplantation: a review. Transplant Int 5:234-246, 1992.
21. Pilepich MV, Anderson CB, Etheredge EE, Sicard GA, Melzer JS, Blum J: Graft irradiation in the treatment of acute rejection of renal transplants: a randomized study. Int J Radiat Oncol Biol Phys 8:823-827, 1982.
22. Platz K-P, Müller AR, Zytowski M, Bechstein W-O, Blumhardt G, Lobeck H, Neuhaus P: OKT3 versus FK 506 rescue management of acute steroid resistant and chronic rejection. Transplant Proc 27:1111-1113, 1995.
23. Rowe PA, Fan KS, Gardiner DS, MacPherson SG, Bradley JA, Rodger RSC, Junor BJR, Briggs JD: Long-term outcome of the use of OKT3 to treat steroid-resistant acute renal allograft rejection Transplant Int 7:278-283, 1994.
24. Sollinger HW, Derhoi MH, Belzer FO, Diethelm AG, Kauffman RS: RS-61443 - a phase 1 clinical trial and pilot rescue study. Transplantation 53:428-432, 1992.
25. Takahara S, Moutabarrik A, Kokado H, Kameoka Y, Takano Y, Zaid D, Ishibashi M, Sonoda T, Okuyama A: Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients. Transplant Proc 25:2254-2258, 1993.
26. Teraoka S, Babazono T, Koike T, Abe M, Kimikawa M, Shinkai M, Haruguchi H, Hirotani S, Kitajima K, Akamatsu M, Ozaki M, Hujita S, Nakajima I, Fuchinoue S, Ota K, Tomonaga O, Yano K, Tasaka Y, Omori Y: Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 27:1335-1339, 1995.
27. Tesi RJ, Elkhammas EA, Henry ML, Ferguson RM: OKT3 for primary therapy of the first rejection episode in kidney transplants. Transplantation 55:1023-1029, 1993.